Author
The author works as a Correspondent with BW Businessworld
Max Healthcare, the Indian healthcare provider headquartered in New Delhi has reported its earnings for the quarter that ended on 31st March 2023, the hospital chain has registered a rise of 26 per cent year on year in its consolidated revenue to be recorded at Rs 1,637 crores in the Quarter Four of Financial Year 2023(Q4FY23) up from Rs 1,296 crores in the corresponding quarter last year
Read More
On the rising medical inflation in India which reports say is approximately at 14 per cent presently and is also the highest in Southeast Asia, Dr Sangita Reddy, Joint MD, Apollo Hospitals said while defending the Indian healthcare costs that the high-quality healthcare in India is available at one-tenth or one-sixth of the global prices and its prices are not high in many areas
Read More
Cipla Limited, the Indian pharmaceutical major headquartered in Mumbai has reported its earnings for the quarter that ended on 31st March 2023, the Indian pharma giant has registered a rise of 8.3 per cent in its consolidated revenue to be recorded at Rs 5,739 crores in the Quarter Four of Financial Year 2022(Q4FY23) up from Rs 5,260 crores in the corresponding quarter last year
Read More
The six strategies of the National Medical Device Policy 2023, propose to augment the growth story of the medical devices industry in India and entail focus areas such as streamlining regulation, enabling infrastructure, facilitating R&D and innovation, inviting investments, facilitating skilled manpower and promoting the industry for exports
Read More
On Tuesday Glenmark Pharmaceuticals stated in an exchange filing that it has agreed to enter into a settlement with the three plaintiff groups who had filed a class action lawsuit against the company in the US court for a total amount of USD 87.5 million related to the generic drug Zetia
Read More
In an exclusive interaction with BW Healthcare World, Chaitanya Sarawate, President and CEO-India & South Asia, GE Healthcare and Managing Director, Wipro-GE, speaks on key digital pillars for healthcare, Chat GPT, reducing import dependence of Indian Medtech, leveraging ER&D and future plans of his company
Read More
Industry experts contend that largely the research budgets of the top firms have remained flattish in the last two to three years on account of Covid, but the scenario might be changing for some select firms like Sun Pharmaceuticals, Dr Reddy’s Labs, Zydus Lifesciences, Cipla and Biocon Biologics among others due a hurting generic pharma industry
Read More
In an exclusive interaction with BW Businessworld, Dr Ashutosh Raghuvanshi, MD & CEO, Fortis Healthcare delineates on the growth of the hospital industry, outcome based payment model, slashing costs, PPP models and the hospital chain’s plans for expansion & acquisitions
Read More
In an exclusive conversation with BW Healthcare World, Kiran Mazumdar Shaw, Executive Chairperson, Biocon & Biocon Biologics delineates on how Indian pharma can move up the value chain, while also speaking on Biocon's R&D investments and future plans
Read More
Online pharmacies in India like Tata 1mg, Netmeds and Pharmeasy among others are in troubled waters again as media reports say that the pharmacies might face a complete ban over the online sale of drugs for alleged violation of norms
Read More
